Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2014 | 1 |
2016 | 1 |
2017 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Optimal duration of adjuvant chemotherapy for high-risk node-negative (N-) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106).
Eur J Cancer. 2017 Jul;79:166-175. doi: 10.1016/j.ejca.2017.03.004. Epub 2017 May 11.
Eur J Cancer. 2017.
PMID: 28501763
Clinical Trial.
Contribution of magnetic resonance imaging of the wrist and hand to forensic age assessment.
Serin J, Rérolle C, Pucheux J, Dedouit F, Telmon N, Savall F, Saint-Martin P.
Serin J, et al.
Int J Legal Med. 2016 Jul;130(4):1121-1128. doi: 10.1007/s00414-016-1362-z. Epub 2016 Mar 30.
Int J Legal Med. 2016.
PMID: 27025715
Item in Clipboard
Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.
Extra JM, Antoine EC, Vincent-Salomon A, Delozier T, Kerbrat P, Bethune-Volters A, Guastalla JP, Spielmann M, Mauriac L, Misset JL, Serin D, Campone M, Hebert C, Remblier C, Bergougnoux L, Campana F, Namer M.
Extra JM, et al.
Oncologist. 2010;15(8):799-809. doi: 10.1634/theoncologist.2009-0029. Epub 2010 Jul 29.
Oncologist. 2010.
PMID: 20671105
Free PMC article.
Clinical Trial.
Item in Clipboard
[Bevacizumab and taxanes in the first-line treatment of metastatic breast cancer : overall survival and subgroup analyses of the ATHENA study in France].
Pierga JY, Delva R, Pivot X, Espié M, Dalenc F, Serin D, Veyret C, Lortholary A, Gligorov J, Joly K, Hernandez J, Hardy-Bessard AC.
Pierga JY, et al.
Bull Cancer. 2014 Sep;101(9):780-8. doi: 10.1684/bdc.2014.2019.
Bull Cancer. 2014.
PMID: 25295737
Clinical Trial.
French.
Item in Clipboard
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
Pivot X, Romieu G, Debled M, Pierga JY, Kerbrat P, Bachelot T, Lortholary A, Espié M, Fumoleau P, Serin D, Jacquin JP, Jouannaud C, Rios M, Abadie-Lacourtoisie S, Venat-Bouvet L, Cany L, Catala S, Khayat D, Gambotti L, Pauporté I, Faure-Mercier C, Paget-Bailly S, Henriques J, Grouin JM; PHARE trial investigators.
Pivot X, et al.
Lancet. 2019 Jun 29;393(10191):2591-2598. doi: 10.1016/S0140-6736(19)30653-1. Epub 2019 Jun 6.
Lancet. 2019.
PMID: 31178155
Clinical Trial.
Item in Clipboard
Cite
Cite